{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:19:04Z","timestamp":1754162344468,"version":"3.41.2"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[1999,9,1]],"date-time":"1999-09-01T00:00:00Z","timestamp":936144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1999,9,1]],"date-time":"1999-09-01T00:00:00Z","timestamp":936144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Epidemiol"],"published-print":{"date-parts":[[1999,9]]},"DOI":"10.1023\/a:1007676625117","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T05:54:50Z","timestamp":1040536490000},"page":"691-698","source":"Crossref","is-referenced-by-count":4,"title":["Prognostic factors correlated with survival in AIDS patients"],"prefix":"10.1007","volume":"15","author":[{"given":"S.","family":"Casari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Donisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Paraninfo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Tomasoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Palvarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Nasta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Bergamasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.P.","family":"Cadeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Carosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"240240_CR1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00002030-198906000-00003","volume":"3","author":"J Batalla","year":"1989","unstructured":"Batalla J, Gatell JM, Cayla JA, Plascencia A, Jansa JM, Parellada N. Predictors of the survival of AIDS cases in Barcelona \u2014 Spain. AIDS 1989; 3: 355\u2013359.","journal-title":"AIDS"},{"key":"240240_CR2","first-page":"144","volume":"4","author":"GH Friedland","year":"1991","unstructured":"Friedland GH, Saltzman B, Vileno J, Freeman K, Schrager LK, Klein RS. Survival differences in patients with AIDS. J AIDS 1991; 4: 144\u2013153.","journal-title":"J AIDS"},{"issue":"2","key":"240240_CR3","first-page":"85","volume":"3","author":"A D'Arminio-Monforte","year":"1992","unstructured":"D'Arminio-Monforte A, Mainini F, Bini T, et al. Fattori di rischio, patologie diagnostiche e sopravvivenza in una coorte di 547 pazienti affetti da AIDS. Giorn Ital AIDS 1992; 3(2): 85\u201390.","journal-title":"Giorn Ital AIDS"},{"issue":"3","key":"240240_CR4","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJM199001183220305","volume":"322","author":"IL Fahey","year":"1990","unstructured":"Fahey IL, Taylor JMG, Detels R, et al. The prognostic value of cellular and serologic markers in infection with Human Immunodeficiency Virus type 1. N Engl J Med 1990; 322(3): 166\u201372.","journal-title":"N Engl J Med"},{"key":"240240_CR5","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1001\/jama.1996.03530410043031","volume":"275","author":"C Enger","year":"1996","unstructured":"Enger C, Graham N, Peng Y, Chmiel JS, Kingsley LA, Detels R, Mu\u00f1oz A. Survival from early, intermediate and late stages of HIV infection. JAMA 1996; 275: 1329\u20131334.","journal-title":"JAMA"},{"key":"240240_CR6","first-page":"694","volume":"5","author":"A Mu\u00f1oz","year":"1992","unstructured":"Mu\u00f1oz A, Vlahov D, Solomon L, et al. Prognostic indicators for development of AIDS among intravenous drug users. J AIDS 1992; 5: 694\u2013700.","journal-title":"J AIDS"},{"key":"240240_CR7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00002030-199501000-00008","volume":"9","author":"L Kehui","year":"1995","unstructured":"Kehui L, Matthew L, Kaldor JM, Mc Donald AM, Cooper DA. The role of initial AIDS-defining illness in survival following AIDS. AIDS 1995; 9: 57\u201363.","journal-title":"AIDS"},{"issue":"12","key":"240240_CR8","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1056\/NEJM199509213331202","volume":"333","author":"RE Chaisson","year":"1995","unstructured":"Chaisson RE, Keruly JC, Moore RD. Race, sex, drug use and progression of Human Immunodeficiency Virus disease. N Engl J Med 1995; 333(12): 751\u2013756.","journal-title":"N Engl J Med"},{"issue":"6","key":"240240_CR9","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1001\/jama.1994.03520060037029","volume":"272","author":"PA Volberding","year":"1994","unstructured":"Volberding PA, Lagakos SW, Grimes JM, et al. The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group. JAMA 1994; 272(6): 437\u2013442.","journal-title":"JAMA"},{"issue":"1","key":"240240_CR10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0163-4453(95)92743-3","volume":"30","author":"L Dorrell","year":"1995","unstructured":"Dorrell L, Snow MH, Ong EL. Mortality and survival trends in patients with AIDS in North-East England from 1984\u20131992. J Infect 1995; 30(1): 23\u201327.","journal-title":"J Infect"},{"key":"240240_CR11","volume-title":"The Statistical analysis of failure time data","author":"JD Kalbfleisch","year":"1980","unstructured":"Kalbfleisch JD, Prentice RL. The Statistical analysis of failure time data. New York: John Wiley & Sons, 1980."},{"key":"240240_CR12","unstructured":"Pulido F, Pe\u00f1a JM, Rubio R, et al. Survival of HIV infected patients after an episode of Tuberculosis (TB). Is TB always an AIDS event? In: 35th ICAAC, San Francisco 17\u201320 sett. 1995, Abstr. K 124, 309."},{"issue":"2","key":"240240_CR13","doi-asserted-by":"crossref","first-page":"100","DOI":"10.7326\/0003-4819-121-2-199407150-00004","volume":"121","author":"DS Stein","year":"1994","unstructured":"Stein DS, Graham NM, Park LP, Hoover DR, Phair JP, Detels R, Ho M, Saah AJ. The effect of the interaction of acyclovir with zidovudine on progression to AIDS and survival. Analysis of data in the Multicenter AIDS Cohort Study. Ann Intern Med 1994; 121(2): 100\u2013108.","journal-title":"Ann Intern Med"},{"issue":"2","key":"240240_CR14","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1017\/S095026880005799X","volume":"114","author":"CA Sabin","year":"1995","unstructured":"Sabin CA, Phillips AN, Lee CA, Janossy G, Emery V, Griffiths PD. The effect of CMV infection on progression of Human Immunodeficiency virus disease in a cohort of haemophilic men followed up to 13 years from seroconvertion. Epidemiol Infect 1995; 114(2): 361\u2013372.","journal-title":"Epidemiol Infect"},{"issue":"3","key":"240240_CR15","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/infdis\/172.3.613","volume":"172","author":"Ocular Complications of AIDS Research Group","year":"1995","unstructured":"Ocular Complications of AIDS Research Group, Antiviral effects of Foscarnet and Ganciclovir therapy on Human Immunodeficiency Virus p24 antigen in patients with AIDS and Cytomegalovirus retinitis. J Infect Dis 1995; 172(3): 613\u2013621.","journal-title":"J Infect Dis"},{"issue":"2","key":"240240_CR16","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/infdis\/172.2.346","volume":"172","author":"JE Gallant","year":"1995","unstructured":"Gallant JE, Moore RD, Keruly J, Richman DD, Chaisson RE. Lack of association between acyclovir use and survival in patients with advanced Human Immunodeficiency Virus disease treated with zidovudine. J Infect Dis 1995; 172(2): 346\u2013352.","journal-title":"J Infect Dis"},{"key":"240240_CR17","unstructured":"Ward JW, Hanson DL, Chu SY, Jones JJ. Survival and trends in anti-retroviral therapy and antimicrobial prophylaxis among persons with 1993\u2013defined AIDS. In: 35th ICAAC, San Francisco 17\u201320 sett. 1995, Abstr. I 168, 235."},{"key":"240240_CR18","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/clinids\/22.3.513","volume":"22","author":"L Saravolatz","year":"1996","unstructured":"Saravolatz L, Neaton JD, Sacks L, Deyton L, Rhame F, Sherer R. CD4+ T-Lymphocyte counts and patterns of mortality among patients infected with Human Immunodeficiency Virus who were enrolled in community programs for clinical research on AIDS. Clin Infect Dis 1996; 22: 513\u2013520.","journal-title":"Clin Infect Dis"},{"key":"240240_CR19","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/infdis\/171.4.829","volume":"171","author":"EG Apolonio","year":"1995","unstructured":"Apolonio EG, Hoover DR, He Y, et al. Prognostic factors in Human Immunodeficiency Virus-positive patients with a CD4+ Lymphocyte count < 50\/\u00b5l. J Infect Dis 1995; 171: 829\u2013836.","journal-title":"J Infect Dis"},{"key":"240240_CR20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/infdis\/172.1.97","volume":"172","author":"PJE Bindels","year":"1995","unstructured":"Bindels PJE, Krol A, Roos M, Veenstra J, van den Hoek JAR, Miedema F, Coutinho RA. The predictive value of T cell function in vitro and pre-AIDS zidovudine use for survival after AIDS diagnosis in a cohort of homosexual men in Amsterdam. J Infect Dis 1995; 172: 97\u2013104.","journal-title":"J Infect Dis"},{"key":"240240_CR21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00002030-199501000-00007","volume":"9","author":"S Vella","year":"1995","unstructured":"Vella S, Giuliano M, Floridia M, et al. Effect of sex, age and transmission category on the progression to AIDS and survival of zidovudine-treated symptomatic patients. AIDS 1995; 9: 51\u201356.","journal-title":"AIDS"}],"container-title":["European Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1007676625117.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1007676625117\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1007676625117.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T04:47:12Z","timestamp":1753850832000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1007676625117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,9]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[1999,9]]}},"alternative-id":["240240"],"URL":"https:\/\/doi.org\/10.1023\/a:1007676625117","relation":{},"ISSN":["0393-2990","1573-7284"],"issn-type":[{"type":"print","value":"0393-2990"},{"type":"electronic","value":"1573-7284"}],"subject":[],"published":{"date-parts":[[1999,9]]}}}